Mektovi (Binimetinib)

Complete patient guide for uses, dosage, side effects, and safety information

Prescription Required

Quick Facts

Generic Name
binimetinib
Drug Class
MEK inhibitors
Used For
Treatment of melanoma and non-small cell lung cancer (NSCLC) in adults
How Taken
Oral tablets, 45 mg twice daily

What Is Mektovi Used For?

Mektovi is an anti-cancer medication that works in combination with another drug called Braftovi to treat specific types of cancer.

Primary Uses

Mektovi is used in combination with Braftovi to treat adults with melanoma that has spread or cannot be surgically removed, and non-small cell lung cancer (NSCLC) that has also spread.

How It Works

Mektovi targets the MEK protein, which promotes cancer cell growth, helping to slow or stop the progression of cancer when used alongside Braftovi, which targets the mutated BRAF protein.

Good to know: Mektovi is not addictive.

Continue Reading

Sign in to access the complete medication guide including dosage, side effects, warnings, and more.

How to Take Mektovi

Follow your doctor's instructions on how to take Mektovi.

Dosage Instructions

The recommended dose is 45 mg, taken as three 15 mg tablets or one 45 mg tablet, twice daily about 12 hours apart, totaling 90 mg per day. Swallow the tablets whole with a full glass of water, with or without food.

What If You Miss a Dose?

If you miss a dose and it's less than 6 hours late, take it as soon as you remember. If it's more than 6 hours late, skip that dose and take your next dose at the usual time. Do not double the dose.

Important: Never take a double dose to make up for a missed one.

Available Tablet Strengths

15mg
15mg Tablet Yellow, Oval • A
45mg
45mg Tablet White to off-white, Oval • 45

Side Effects

Like all medications, this medicine can cause side effects. Most are mild and temporary, but some require medical attention.

Common Side Effects

These side effects occur relatively frequently and usually don’t require emergency care:

  • Fatigue
  • Nausea
  • Diarrhea
  • Vomiting
  • Vision problems
  • Stomach pain
  • Joint pain
  • Abnormal blood test results
  • Muscle pain

Seek immediate medical attention if you experience:

  • Heart problems
  • Blood clots
  • Severe bleeding
  • Eye problems
  • Liver issues
  • Muscle breakdown (rhabdomyolysis)
  • High blood pressure
  • Lung or breathing problems
  • Tumor lysis syndrome

Important Warnings

There are several important warnings to consider before using Mektovi.

Who Should Not Take Mektovi

Do not use Mektovi if you are allergic to binimetinib or any of its ingredients.

Medical Conditions to Discuss

Discuss any history of heart problems, high blood pressure, muscle issues, blood clots, liver or lung problems, bleeding issues, and eye conditions with your doctor.

Pregnancy and Breastfeeding

Mektovi is not recommended during pregnancy as it may cause harm to an unborn baby. It is also not recommended while breastfeeding.

Drug Interactions

Certain medications may interact with Mektovi and affect its efficacy.

  • Any other medications that may increase bleeding risk
  • Other treatments for cancer

Alcohol & Driving

Be cautious when driving or operating machinery while taking Mektovi, as it may affect your ability.

Alcohol

Consult your doctor about alcohol consumption while on Mektovi.

Driving and Operating Machinery

Mektovi may impair your ability to drive or operate machinery, especially if you experience vision problems.

Storage

Store Mektovi in its original packaging below 30°C in a cool, dry place, away from moisture and heat.

Overdose Information

If you suspect an overdose, seek immediate medical attention. Contact your doctor or the Poisons Information Centre at 13 11 26.

Frequently Asked Questions

The time it takes for Mektovi to work can vary by individual, and your doctor will monitor your progress.

Yes, Mektovi can be taken with or without food.

No, Mektovi is not considered addictive.

Do not stop taking Mektovi without consulting your doctor, as it may affect your treatment.

Consult your doctor regarding alcohol consumption while on Mektovi.

Weight gain is not commonly reported as a side effect of Mektovi.

Elderly patients should discuss their health conditions with their doctor to ensure Mektovi is safe for them.

If you miss a dose, take it as soon as you remember if it's less than 6 hours late; otherwise, skip it and continue with your schedule.

Important Disclaimer

This information is intended for general educational purposes only and should not be considered medical advice. Always consult your healthcare provider or pharmacist before starting, stopping, or changing any medication.

If you think you may have a medical emergency, call your doctor or emergency services immediately.

Create a free account to access the full medication guide.

Sign in to access your medication guides.